project44 Opens Paris Office to Accelerate European Expansion
4.12.2019 03:24:00 EET | Business Wire | Press release
project44, the global leader in advanced visibility for shippers and logistics service providers, today announced the opening of a new European office in Paris, France. project44 Senior Vice President of EMEA, Renaud Houri, will oversee the office and further build on project44’s European momentum, leading the company’s expanded growth across the region.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191203006111/en/
project44 Senior Vice President of EMEA, Renaud Houri, will oversee the new Paris office and further build on project44’s European momentum, leading the company’s expanded growth across the region (Photo: Business Wire)
Following the acquisition of GateHouse Logistics, Europe’s leading visibility provider based in Denmark, in December 2018, project44 has built the largest visibility network available in the market representing coverage across more than 48 countries, integrations with 600+ telematics providers, and connections to more than 8.5M vehicles worldwide.
project44 has developed the industry’s only fully automated and secure carrier onboarding application, which can connect European Truckload carriers into its Advanced Visibility Platform™ within hours. Unlike other visibility providers that rely on manual onboarding methods, this unique approach to connectivity enables project44 to offer highly compliant advanced visibility coverage to its customers across Europe starting on day one.
“To meet evolving customer demands, global businesses are transforming their supply chains, requiring high-fidelity, real-time insight into their entire shipment process, regardless of region. Expanding our visibility coverage into new regions allows our customers to gain an end-to-end view into their global, multimodal shipments,” stated project44 Founder and CEO Jett McCandless. “Renaud has substantial experience helping global supply chains and organizations take a hyper-local approach. We’re excited to have him join the team and lead our European efforts.”
Prior to joining project44 in July 2019, Houri held various sales leadership positions at SaaS companies and in the logistics and transportation industry, including Senior Vice President of Global Business Development at Shippeo; Senior Vice President of Central, Eastern, and Southern Europe at Trace One; and Vice President and General Manager of EMEA at IBM DemandTec. His experience leading organizations in Europe for global companies will be imperative as project44 continues expansion in Europe and beyond.
“While many supply chains are global, it’s critical to understand the nuisances of local markets in order to streamline operations and reduce costs. project44 is dedicated to providing the value of a single visibility provider,” commented Houri. “I look forward to supporting organizations throughout Europe, enabling our customers to build a more efficient supply chain and provide an unmatched customer experience.”
As project44’s second European location, the Paris office will allow the visibility provider to better support customers across Europe. In addition to their European offices in Denmark and France, project44 has local teams in Germany, Netherlands, Italy, and Spain. With global customers, including many leading retailers, manufacturers and logistics service providers based in Europe, project44’s local teams are able to account for the distinct attributes of regional logistics operations, provide better support to customers across several time zones, and deliver documentation and materials in more than 13 languages.
To learn more visit www.project44.com or contact info@project44.com.
About project44
project44 is the world’s leading advanced visibility platform for shippers and logistics service providers. project44 connects, automates and provides visibility into key transportation processes to accelerate insights and shorten the time it takes to turn those insights into actions. Leveraging the power of the project44 cloud-based platform, organizations are able to increase operational efficiencies, reduce costs, improve shipping performance, and deliver an exceptional Amazon-like experience to their customers. Connected to thousands of carriers worldwide and having comprehensive coverage for all ELD and telematics devices on the market, project44 supports all transportation modes and shipping types, including Parcel, Final-Mile, Less-than-Truckload, Volume Less-than-Truckload, Truckload, Rail, Intermodal, and Ocean.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191203006111/en/
Contact information
Ally Lynch
ally@project44.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Consortium Led by Axelspace Selected for Japan’s Space Strategy Fund Project “Technology to Enhance Capability of Next Generation Earth Observation Satellites”30.3.2026 02:35:00 EEST | Press release
Axelspace Corporation, Meisei Electric Co., Ltd., ANA HOLDINGS INC., and JIJ Inc. are pleased to announce that their jointly proposed technology development project has been selected for Japan Aerospace Exploration Agency (JAXA)’s Space Strategy Fund under the theme “Technology to Enhance Capability of Next Generation Earth Observation Satellites.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323044518/en/ Conceptual Diagram of the project. Under this Space Strategy Fund initiative, spectrometers will be newly developed and demonstrated in orbit. In the future, the project envisions the establishment of a satellite constellation capable of observations at different times of the day. Project Summary (Planned) Technology Development Theme: Technology to Enhance Capability of Next Generation Earth Observation Satellites Project Title: Source-Specific CO2 Emission and Uptake Monitoring through Satellite Constellation and Ai
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 21:00:00 EET | Press release
Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasoc
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 21:00:00 EET | Press release
Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT). “The 54-week results from the STOP-HS program deliver compelling, long-term evidence supporting the potential of povorcitinib for patients with moderate to severe HS,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “Across both studies, povorcitinib demonstrated substantial and durable improvements over time in key measures of treatment success and meaningful clinical ben
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 17:00:00 EET | Press release
Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-breaking session at the 2026 American Academy of Dermatology (AAD) Annual Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260328320362/en/ Atopic dermatitis is the most common inflammatory skin disorder in children, yet treatment options in the moderate-to-severe pediatric setting are limited.5 The disease can have a significant impact on quality of life for both the patients and their loved ones, with persistent itch and recurrent skin lesions often disrupting sleep, school and relationships.5-8 “Atopic dermatitis can affect many aspects of children’s lives including schoolwork, emotional development
Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 21:56:00 EET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom